Table 2 Correlation of serum miRNA expression with clinicopathological parameters. miR-122-5p and miR-206 serum levels were significantly increased in metastasized ccRCCs. Additionally miR-122-5p expression was significantly increased in advanced Fuhrman Grade and miR-206 in advanced pT-stage
From: Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
Number (%) | miR-122-5p (p value) | miR-206 (p value) | |
|---|---|---|---|
pT-stage | 0.145 | 0.007 | |
pT1/2 | 44 (64.7) | ||
pT3/4 | 24 (35.3) | ||
pN-stage | 0.069 | 0.426 | |
pN0 | 64 (94.1) | ||
pN1 | 4 (5.9) | ||
pM-stage | 0.045 | 0.003 | |
pM0 | 57 (83.8) | ||
pM1 | 11 (16.2) | ||
Fuhrman Grading | 0.001 | 0.053 | |
G1/2 | 47 (69.1) | ||
G3/4 | 21 (30.9) | ||